Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology
(Adnkronos) – Sale of Indivumed’s Service Business to Crown Bioscience Enables Creation of Oncology R&D Powerhouse HAMBURG, Germany, April 4, 2023 /PRNewswire/ — After twenty years as one of the first personalized
